▲ 3 r/ALS
Plasma NfL, GFAP and pTau181 define distinct biological axes in amyotrophic lateral sclerosis
Slow but steady Progress in biomarkers. This is important for Dx & evaluation of pharmaceutical concepts and efficacy in CTs & EAPs.
The identification of three latent biomarker profiles further supports the presence of biologically meaningful ALS subgroups.
u/DyingofHappiness — 5 days ago